Comparison of Immunity in Mice Cured of Primary/Metastatic Growth of EMT6 or 4THM Breast Cancer by Chemotherapy or Immunotherapy

PURPOSE: We have compared cure from local/metastatic tumor growth in BALB/c mice receiving EMT6 or the poorly immunogenic, highly metastatic 4THM, breast cancer cells following manipulation of immunosuppressive CD200:CD200R interactions or conventional chemotherapy. METHODS: We reported previously t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorczynski, Reginald M., Chen, Zhiqi, Erin, Nuray, Khatri, Ismat, Podnos, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237434/
https://www.ncbi.nlm.nih.gov/pubmed/25409195
http://dx.doi.org/10.1371/journal.pone.0113597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237434/
https://www.ncbi.nlm.nih.gov/pubmed/25409195
http://dx.doi.org/10.1371/journal.pone.0113597

Ejemplares similares